Cantargia AB
Cantargia AB
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunoprevention for High-risk Lung Lesions | High-risk Lung Nodules | Recruiting | Phase 2 | 2026-06-08 | NCT07284485 | |
| Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 1 / Phase 2 | 2026-02-19 | NCT07281716 |